News

Abbott in collaboration with IQVIA highlights that 44% of people have been living with vertigo for more than a year, experiencing episodes once a week. Many mistake vertigo for low blood sugar, low ...
LUMA Vision receives US FDA clearance for Verafeye 2D/4D cardiac visualization platform: Dublin Thursday, April 17, 2025, 16:00 Hrs [IST] LUMA Vision Ltd, an innovative leader in ...
Sterling Accuris strengthens presence in diagnostics through acquisition of Gujarat Pathology Laboratory and Diagnostic Centre: Our Bureau, Mumbai Thursday, April 17, 2025, 15:45 ...
ImmunityBio announces US FDA submissions of sBLA for NMIBC papillary disease and EAP for Anktiva to treat lymphopenia: Culver City, Calif Thursday, April 17, 2025, 15:00 Hrs [IST] ...
Oncodesign Services, a contract research organization specializing in drug discovery and preclinical development, appointed Dr. Aidan Synnott as chief executive officer, to help strengthen its ...
Novartis appoints Karen Hale as chief legal and compliance officer: Basel Tuesday, April 1, 2025, 13:00 Hrs [IST] Novartis announced the appointment of Karen Hale to the expanded ...
Jay Bhattacharya begins tenure as 18th director of the National Institutes of Health: Bethesda, Maryland Thursday, April 3, 2025, 13:00 Hrs [IST] Jayanta “Jay” Bhattacharya, M ...
B. Braun introduces Ezcover Probe Cover Set for improved ultrasound safety in peripheral nerve block procedures: Bethlehem, Pennsylvania Thursday, April 17, 2025, 14:00 Hrs [IST] ...
Belhaven Biopharma announces promising study results from its dose confirmational clinical trial of Nasdepi: Raleigh, North Carolina Thursday, April 17, 2025, 13:00 Hrs [IST] Belh ...
Venus Remedies’ novel polymyxin B formulation, VRP-034 gets US FDA QIDP designation: Our Bureau, Bengaluru Thursday, April 17, 2025, 12:15 Hrs [IST] Venus Remedies’ investigat ...
QIAGEN to launch three new sample preparation instruments by 2026 to improve lab automation: Venlo, Netherlands Thursday, April 17, 2025, 11:00 Hrs [IST] QIAGEN, leading global pr ...